Pilot study of a specific dietary supplement in tumor-bearing mice and in stage IIIB and IV non-small cell lung cancer patients

Nutrition and Cancer

Volumn 39, Issue 1, 2001, Pages 85-95

  Sun, Alexander S ^a   Yeh, Hsu Chong ^b   Wang, Lu Hai ^b   Huang, Yun Peng ^b   Maeda, Hiroshi ^c   Pivazyan, Arman ^d   Hsu, Ching ^e   Lewis, Ellen R ^a   Bruckner, Howard W ^f   Fasy, Thomas M ^b  

^a Connecticut Institute for Aging and Cancer ^*  (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

^f ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COUMESTROL; GENISTEIN; PHYTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN METASTASIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; GROWTH INHIBITION; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PILOT STUDY; SURVIVAL TIME; TUMOR GROWTH; VEGETABLE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; COUMESTROL; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FEMALE; GENISTEIN; HUMANS; ISOFLAVONES; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; NEOPLASM STAGING; NUTRITIVE VALUE; PHYTIC ACID; PILOT PROJECTS; SURVIVAL ANALYSIS; TIME FACTORS; VEGETABLES;

ANIMALIA;

EID: 0034833452     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914nc391_12     Document Type: Article

References (52)

1. Cancer statistics, 1998
2. Future directions in the treatment of non-small cell lung cancer
3. Revisions in the international system for staging lung cancer
4. Regional lymph node classification for lung cancer staging
5. Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small cell lung cancer: A phase 1-11 study
6. Front-line treatment of advanced non-small cell lung cancer with docetaxel and gemcitabine: A multicenter phase II trial
7. Plants used against cancer: A survey
8. Inhibition of mouse sarcoma 180 by polysaccharides from Lentinus edodes (Berk.) Sing
9. Lentinan, a new immune-accelerator of cell-mediated responses
10. Induction of endogenous lymphokine-activated killer activity by combined administration of lentinan and interleukin 2
11. Enhanced production of interleukin I and tumor necrosis factor by peripheral monocytes after lentinan administration in patients with gastric carcinoma
12. Enhanced induction of lymphokine-activated killer activity after lentinan administration in patients with gastric carcinoma
13. Synergistic induction of lymphokine (IL-2)-activated killer activity by IL- 2 and polysaccharide lentinan and therapy of spontaneous pulmonary metastases
14. Anticancer polysaccharides, lentinan and pachymaran as immunopotentiators
15. Antiviral and interferon-inducing activities of a new peptidomannan, KS-2, extracted from culture mycelia of Lentinus edodes
16. Intestinal absorption and urinary excretion of anticancer peptidomannan KS-2 after oral administration in rats
17. Immunomodulatory substances of fungal origin
18. The evidence for soybean products as cancer preventive agents
19. Saponins as anticarcinogens
20. Inositol phosphates have novel anticancer function
21. Inositol phosphate-induced enhancement of natural cell activity correlates with tumor suppression
22. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation
23. Effect of genistein on in vitro and in vivo models of cancer
24. Genistein, a dietary-derived inhibitor of in vitro angiogenesis
25. Evaluation of the biochemical targets of genistein in tumor cells
26. Soy intake and cancer risk: A review of the in vitro and in vivo data
27. Phase I/II study of stage III and IV non-small cell lung cancer patients taking a specific dietary supplement
28. Quantitation of phytoestrogens in legumes by HPLC
29. Quantitative determination of phytate in the presence of high inorganic phosphate
30. Reduced tumorigenicity ora spontaneous mouse lung carcinoma following H-2 gene transfection
31. The use of nitrogen mustards in the palliative treatment of carcinoma with particular reference to bronchogenic carcinoma
32. Nonparametric estimation from incomplete observations
33. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials
34. SMANCS and polymer-conjugated macromolecular drugs: Advantages in cancer chemotherapy
35. The causes and prevention of cancer
36. Theory and practice of clinical trials
37. Treatment of brain metastases from primary lung cancer
38. CT characteristics of patients with brain metastases treated in RTOG study 79-16
39. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age
40. Psychosocial correlates of cancer survival: A subsequent report 3 to 8 years after cancer diagnosis
41. Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy
42. Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer
43. Survival predictors in advanced non-small cell lung cancer
44. Karnofsky and ECOG performance status scoring in lung cancer: A prospective, longitudinal study of 536 patients from a single institution
45. Can Karnofsky performance status be transformed to the Eastern Cooperative Oncology Group scoring scale and vice versa?